.2008 .Evaluation of the current knowledge limitations in breast cancer research: a gap analysis. Breast Cancer Research, 2(12) : 348-365.
Taplin S,Abraham L,Barlow W. .2008 .Mammography facility characteristics associated with interpretive accuracy of screening mammography. Journal National Cancer Institute, 100(12) : 876-887.
Uehara M,Kinoshita T,Hojo T.,Akashi-Tanaka S,Iwamoto E .2007 .Long-term prognostic study of carcinoembryonic antigen (CEA) and carbohydrate antigen 15-3 (CA 15-3) in breast cancer. International Journal Clinical Oncology, 13 : 447-451.
Kinoshita T,Hojo T. .2007 .Long-term prognostic study of carcinoembryonic antigen (CEA) and carbohydrate antigen 15-3 (CA 15-3) in breast cancer. International Journal Clinical Oncology, 13(9) : 447-451.
Feng Y,Spezia M,Huang S,Yuan C,Zeng Z,Pathogenesis Molecular,Disease Molecular .2018 .Breast Cancer Development and Progression: Risk Factors, Cancer Stem Cells, Signaling Pathways. , 5(2) : 77-106.
Elango R,Alsaleh K,Vishnubalaji R,Manikandan M,Ali A .2020 .MicroRNA Expression Profiling on Paired Primary and Lymph Node Metastatic Breast Cancer Revealed Distinct microRNA Profile Associated With LNM. , 19 : 756.
Reviews Molecular Cell Nature,Biology Nature .2019 .. , 20(1) : 5-20.
Krol J,Loedige I,Filipowicz W. .2010 .Function and Decay. Nature Reviews Genetics, 11(9) : 597-610.
Abak A,Amini S,Estiar MA,Montazeri V,Sakhinia E .2018 .Analysis of miRNA-221 Expression Level in Tumors and Marginal Biopsies From Patients With Breast Cancer (CrossSectional Observational Study). Clinical Labortory, 64(1) : 169-175.
Smyth GK .2004 .; 3: Article 3. Statistical Applications in Genetics and Molecular Biology, : .
Bahmanpour Z,Sheervalilou R,Choupani J,Shekari K,Montazeri V .2019 .A new insight on serum microRNA expression as novel biomarkers in breast cancer patients. Journal Cell Physiology, 234(11) : 19199-19211.
Bartels C .2009 .MicroRNAs: novel biomarkers for human cancer. Clinical Chemistry, 55(4) : 623-631.
Opstal-van W,Rodenburg W,Pennings J,van Oostrom C,Beijnen J .2012 .A bead-based multiplexed immunoassay to evaluate breast cancer biomarkers for early detection in prediagnostic serum. International Journal Molecular Sciences, 13(10) : 13587-13604.
Jang K,Ahn H,Sim J,Han H,Abdul R H .2014 .Loss of microRNA-200a expression correlates with tumor progression in breast cancer. Translational Research, 163(3) : 242-251.
Hafez M,Hassan Z,Zekri A,Gaber A,Al Rejaie S .2012 .MicroRNAs and metastasis-related gene expression in Egyptian breast cancer patients. Asian Pacific Journal of Cancer Prevention, 13(2) : 591-598.
Pencheva N,Tavazoie S. .2013 .Control of metastatic progression by microRNA regulatory networks. Nature Cell Biology, 15 : 546-554.
Li D,Zhao Y,Liu C,Chen X,Qi Y .2011 .and role in breast cancer. Clinical Cancer Research, 17 : 1722-1730.
Hannafon B,Sebastiani A,Lu J,Rosenberg C. .2011 .Expression of microRNA and their gene targets are dysregulated in preinvasive breast cancer. Breast Cancer Research, 13(2) : R24.
Zhao F,Dou Y,Wang X,Han D,Lv Z .2014 .Serum microRNA-195 is down-regulated in breast cancer: a potential marker for the diagnosis of breast cancer. Molecular Biology Report, 41(9) : 5913-5922.
Deng H,Guo Y,Song H,Xiao B,Sun W .2013 .-195 and microRNA-378 mediate tumor growth suppression by epigenetic regulation in gastric cancer. Gene, 518(2) : 351-359.
Yu W,Liang X,Li X,Zhang Y,Sun Z .2018 .-195: a review of its role in cancers. Oncotargets and therapy. , 11 : 7109-7123.
Shao Y,Sun X,He Y,Liu C,Liu H .2015 .Elevated levels of serum tumor markers CEA and CA15-3 are prognostic parameters for different molecular subtypes of breast cancer. PLoS One, 10(7) : e133830.
Nadeem F,Hanif M,Ahmed A,Jamal Q,Khan A .2017 .Clinicopathological features associated with MiRNA-195 expression in patients with breast cancer: evidence of a potential biomarker. Pakistan Journal of Medical Sciences, 33(5) : 1242-1247.
Luo Q,Wei C,Li X,Li J,Chen L .2014 .-195-5p is a potential diagnostic and therapeutic target for breast cancer. Oncology Report, 31(3) : 1096-1102.
Kumar V,Abbas A.K,Fausto N,Aster J.,Robbins J. .2014 .. Cotran Pathologic Basis of Disease Elsevier: health sciences,, : .
Ye F,Tang H,Liu Q. . .miR-200b as a prognostic factor in breast cancer targets multiple members of the RAB family. , : .
.2014 .. Journal of Translational Medicine, 12(17) : 1-10.
Hong H,Yu H,Yuan J,Guo C,Cao H .2016 .-200b Impacts Breast Cancer Cell Migration and Invasion by Regulating Ezrin-Radixin-Moesin. Medical Sciences Monitor, 8(22) : 1946-1952.
He M,Liu Y,Deng X,Qi S,Sun X .2013 .Down-regulation of miR-200b-3p by low p73 contributes to the androgenindependence of prostate cancer cells. Prostate, 73(10) : 1048-1056.
Cai Z,Zhang S,Zhang H,Zhou Y,Wu H .2013 .Aberrant expression of microRNAs involved in epithelialmesenchymal transition of HT-29 cell line. Cell Biology, 37(7) : 669-674.
.2013 .The microRNA-200 family targets multiple non-small cell lung cancer prognostic markers in H1299 cells and BEAS-2B cells. International Journal Oncology, 43 : 548-560.
Yoshino H,Enokida H,Itesako T,Tatarano S,Kinoshita T .2013 .Epithelial-mesenchymal transition-related microRNA200s regulate molecular targets and pathways in renal cell carcinoma. Juornal Human Genet, 58 : 508-516.
Castilla M,Díaz-Martín J,Sarrió D,Romero-Pérez L,LópezGarcía M .2012 .-200 family modulation in distinct breast cancer phenotypes. PLoS One, 7(10) : e47709.
.2011 .Dynamic epigenetic regulation of the microRNA-200 family mediates epithelial and mesenchymal transitions in human tumorigenesis. Oncogene, 31 : 2062-2074.
Kang L,Mao J,Tao Y,Song B,Ma W .2015 .(. Cancer Sciences, 106 : 700-708.
Papachristopoulou Papadopoulos E.,Ardavanis G,Scorilas A,A A .2018 .A comprehensive clinicopathological evaluation of the differential expression of microRNA-331 in breast tumors and its diagnostic significance. Clinical Biochemistry, 60 : 24-32.
Chang R,Yang H,Fang F,Xu J,Yang L. MicroRNA- J .2014 .-3p promotes proliferation and metastasis of hepatocellular carcinoma by targeting PH domain and leucine-rich repeat protein phosphatase. Hepatology, 60 : 1251-63.
Chen X,Luo H,Li X,Tian X,Peng B .2018 .-3p functions as an oncogene by targeting ST7L in pancreatic cancer. Carcinogenesis, 39(8) : 1006-1015.
. .MicroRNA331-3p Suppresses Cervical Cancer Cell Proliferation and E6/E7 Expression by Targeting NRP2. , : .
.2016 .. International Journal Molecular Sciences, 17(8) : 13-51.
Zhao D,Sui Y,Zheng X. MiR- Y . .-3p inhibits proliferation and promotes apoptosis by targeting HER2 through the PI3K/Akt and ERK1/2 pathways in colorectal cancer. , : .
Oncology Report .2016 .. , 35(2) : 1075-1082.
MicroRNA- .2019 .-3p inhibits proliferation and metastasis of ovarian cancer by targeting RCC2. Archives of Medical Sciences,(. , 15(6) : 1520-1529.
Butrym A,Rybka J,Baczyńska D,Tukiendorf A,Kuliczkowski K .2018 .Expression of microRNA-331 can be used as a predictor for response to therapy and survival in acute myeloid leukemia patients. , 9(5) : 453-460.
Reviews Clinical Nature,Oncology Nature .2014 .. , 11(3) : 145-156.
Roth C,Rack B,Muller V. .2010 .Circulating microRNAs as bloodbased markers for patients with primary and metastatic breast cancer. Breast Cancer Research, 12 : R90.
Van Schooneveld E,Wouters M,van der Auwera I,Peeters D,Wildiers H .2012 .Expression profiling of cancerous and normal breast tissues identifies microRNAs that are differentially expressed in serum from patients with (metastatic) breast cancer and healthy volunteers. Breast Cancer Research, 14(1) : R34.
Pigati L,Yaddanapudi S,Iyengar R .2010 .Selective release of microRNA species from normal and malignant mammary epithelial cells. PLoS One, 5 : e13515.
Witwer K. Circulating .2015 .microRNA biomarker studies: pitfalls and potential solutions. Clinical Chemistry, 61(1) : 56-63.
Valadi H,Ekstrom K,Bossios A .2007 .Exosomemediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nature Cell Biology, 9 : 654-659.
PLoS One .2012 .. , 7 : e30679.
Turchinovich A,Weiz L,Burwinkel B .2012 .Extracellular miRNAs: the mystery of their origin and function. Trends Biochemistry Sciences, 37 : 460-465.
Arroyo J. Chevillet J. Kroh E. .2011 .Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proceedings of the National Academy of Sciences of the United States of America, 108(12) : 5003-5008.
Prevention Research Cancer .2012 .. , 5(3) : 492-497.
. .To read the copy of this license please visit: https://creativecommons. , : .